Leveraging AI to help patients who suffer from common neurological conditions such as epilepsy.
One percent (1%) of the world population suffers from epilepsy, seizures, and related head injuries from falls. The need for a patient worn monitor to provide an advanced warning has long been recognized. However, no commercial algorithm exists to make such a a seizure onset prediction warn a patient. TheraNeuroAI has developed a prediction algorithm that expects to provides a 10+ minute warning prior to a seizure for 90% of the patient population with 90% accuracy. Doing so is a game changer. The market for such a device and monitoring services is estimated at $360m/year for each 1% share in the US alone. Worldwide market is estimated at 3x this.
TheraNeuro has deep expertise in artificial intelligence, algorithm development and medical device and diagnostic devices.